PMID: 9450858Feb 5, 1998Paper

Is hereditary site-specific ovarian cancer a distinct genetic condition?

American Journal of Medical Genetics
A LiedeW Foulkes

Abstract

It is not clear if hereditary site-specific ovarian cancer exists as a genetic entity distinct from the hereditary breast-ovarian cancer syndrome. We have identified a large Ashkenazi Jewish kindred with 8 cases of ovarian carcinoma and no cases of breast cancer. Initially, linkage analysis for this kindred generated a negative LOD score to BRCA1, but subsequent mutation and haplotype analysis of key individuals demonstrated a BRCA1 185delAG mutation segregating with all but 1 of the ovarian cancer cases. This observation has important implications for genetic counselling of families with site-specific ovarian cancer. Hereditary site-specific ovarian cancer is likely to be a variant of the hereditary breast-ovarian cancer syndrome, attributable to either BRCA1 or BRCA2. We consider women from these families to be at increased risk of breast cancer and counsel them accordingly.

References

Dec 1, 1986·The American Journal of Medicine·H T LynchJ F Lynch
Dec 20, 1995·International Journal of Cancer. Journal International Du Cancer·S A NarodH Lynch
May 15, 1997·The New England Journal of Medicine·J P StruewingM A Tucker

❮ Previous
Next ❯

Citations

Mar 20, 1999·BMJ : British Medical Journal·L KasprzakA N Shelling
Aug 12, 1999·American Journal of Human Genetics·A DørumP Møller
Jan 1, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O JohannssonH Olsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.